Showing results (531-540 of 671) with videos related to
Sort By:
Pageof 68
Oncogene|December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|December 27, 2019
Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver ConcordanceTheresa A Boyle, Farah K Khalil, Mari Mino-Kenudson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.Oncogene|November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung CancerM Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2020
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung CancerMatthew P Smeltzer, Murry W Wynes, Sylvie Lantuejoul, et al.The Lancet. Oncology|October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.Cancer Research|December 20, 2018
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i>-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkMarta Román, Inés López, Elisabeth Guruceaga, et al.Cancer Cell|June 16, 2023
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinomaYu Qian, Ana Galan-Cobo, Irene Guijarro, et al.Cancer Research|May 25, 2016
Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing AirwayYasminka Jakubek, Wenhua Lang, Selina Vattathil, et al.Pageof 68